RESUMEN
The A.A.E.E.H has developed this guideline for the best care of patients with hepatocellular carcinoma (HCC) from Argentina. It was done from May 2018 to March 2020. Specific clinical research questions were systematically searched. The quality of evidence and level of recommendations were organized according to GRADE. HCC surveillance is strongly recommended with abdominal ultrasound (US) every six months in the population at risk for HCC (cirrhosis, hepatitis B or hepatitis C); it is suggested to add alpha-feto protein (AFP) levels in case of inexeperienced sonographers. Imaging diagnosis in patients at risk for HCC has high specificity and tumor biopsy is not mandatory. The Barcelona Clinic Liver Cancer algorithm is strongly recommended for HCC staging and treatment-decision processes. Liver resection is strongly recommended for patients without portal hypertension and preserved liver function. Composite models are suggested for liver transplant selection criteria. Therapies for HCC with robust clinical evidence include transarterial chemoembolization (TACE) and first to second line systemic treatment options (sorafenib, lenvatinib, regorafenib, cabozantinib and ramucirumab). Immunotherapy with nivolumab and pembrolizumab has failed to show statistical benefit but the novel combination of atezolizumab plus bevacizumab has recently shown survival benefit over sorafenib in frontline.
Asunto(s)
Carcinoma Hepatocelular/terapia , Técnicas de Apoyo para la Decisión , Neoplasias Hepáticas/terapia , Oncología Médica/normas , Estadificación de Neoplasias/normas , Algoritmos , Argentina , Biopsia/normas , Carcinoma Hepatocelular/diagnóstico por imagen , Carcinoma Hepatocelular/mortalidad , Carcinoma Hepatocelular/patología , Toma de Decisiones Clínicas , Consenso , Medicina Basada en la Evidencia/normas , Humanos , Neoplasias Hepáticas/diagnóstico por imagen , Neoplasias Hepáticas/mortalidad , Neoplasias Hepáticas/patología , Valor Predictivo de las Pruebas , Medición de Riesgo , Factores de Riesgo , Resultado del Tratamiento , Ultrasonografía/normasRESUMEN
PURPOSE: There is no standardized approach for preserving olfactory function in the side of the nose where biopsy of the olfactory epithelium (OE) is performed. Moreover, a gold standard technique for obtaining human OE in vivo is still lacking. We determined the efficacy of obtaining good-quality OE specimens suitable for pathological analysis from the lower half of the superior turbinate and verified the safety of this procedure in maintaining bilateral and unilateral olfactory function. METHODS: In 21 individuals without olfactory complaints and who had undergone septoplasty and inferior turbinectomy OE biopsy was made during septoplasty. Olfactory function, both unilateral and bilateral, was assessed using the University of Pennsylvania Smell Identification Test (UPSIT) before and 1 month after the procedure. Specimens were marked with the olfactory marker protein for confirmation of OE presence. RESULTS: Ninety percent of the samples contained OE, although clear histological characterization was possible from only 62%. There was no deterioration of UPSIT scores either bilaterally or unilaterally on the side of the biopsy. Patients also maintained the ability to identify individual odorants. CONCLUSION: Biopsies of the lower half of the superior turbinate do not affect olfactory function and show strong efficacy in yielding OE tissue and moderate efficacy for yielding tissue appropriate for morphological analysis. Future studies are needed to assess the safety of this procedure in other OE regions.
Asunto(s)
Mucosa Olfatoria/fisiología , Olfato/fisiología , Cornetes Nasales/fisiología , Adolescente , Adulto , Biopsia/normas , Femenino , Humanos , Masculino , Odorantes , Mucosa Olfatoria/anatomía & histología , Mucosa Olfatoria/cirugía , Resultado del Tratamiento , Cornetes Nasales/anatomía & histología , Cornetes Nasales/cirugía , Adulto JovenRESUMEN
The optimal duration of maintenance immunosuppressive therapy for patients with lupus nephritis who have achieved clinical remission has not been established. Furthermore, clinical and histologic remissions are often discordant. We postulated that continuing therapy for patients with persistent histologic activity on kidney biopsies done during maintenance and discontinuing therapy only for patients without histologic activity would minimize subsequent lupus nephritis flares. To test this, a cohort of 75 prospectively-followed patients with proliferative lupus nephritis was managed using kidney biopsies performed during maintenance therapy. These patients had been on immunosuppression for at least 42 months, had responded, and had maintained their clinical response for at least 12 months before the kidney biopsy was repeated. Maintenance therapy was withdrawn if the biopsy showed an activity index of zero, but was continued if the biopsy showed an activity index of one or more. A lupus nephritis flare developed in seven patients during the average 50 months from the third biopsy and the final clinic visit for a flare rate of 1.5/year; significantly less than reported flare rates. Baseline clinical parameters (serum creatinine, proteinuria) and serologic parameters (complement C3, C4 and anti-dsDNA) did not predict an activity index of zero on the third biopsy or who would have a lupus nephritis flare. No patients developed end-stage kidney disease. Four patients developed de novo chronic kidney disease. There were no serious adverse events related to biopsy. Thus, at an experienced center, biopsy-informed management of maintenance immunosuppression is safe and may improve the lupus nephritis flare rate compared to conventional clinical management.
Asunto(s)
Inmunosupresores/administración & dosificación , Fallo Renal Crónico/prevención & control , Riñón/patología , Nefritis Lúpica/tratamiento farmacológico , Administración del Tratamiento Farmacológico , Adulto , Biopsia/normas , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Inmunosupresores/efectos adversos , Riñón/efectos de los fármacos , Riñón/inmunología , Fallo Renal Crónico/inmunología , Nefritis Lúpica/complicaciones , Nefritis Lúpica/diagnóstico , Nefritis Lúpica/inmunología , Quimioterapia de Mantención/efectos adversos , Quimioterapia de Mantención/métodos , Masculino , Brote de los Síntomas , Adulto JovenRESUMEN
PURPOSE OF REVIEW: The purpose of this review is to summarize the most current literature regarding the most important aspects to consider when developing a center of excellence for prostate imaging and biopsy. RECENT FINDINGS: Multiparametric MRI (mp-MRI) has changed the way we diagnose and treat prostate cancer. This imaging modality allows for more precise identification of areas suspicious in terms of harboring prostate cancer, enabling performance of targeted mp-MRI-guided biopsies that have been demonstrated to yield superior cancer detection rates. Centers worldwide are increasingly adopting this technology. However, obtaining results comparable with those findings published in the literature can be challenging. The imaging and biopsy process entails the need for a multidisciplinary team including a dedicated radiologist, urologist, and pathologist. Adequate mp-MRI interpretation for accurate lesion identification, acquaintance with the biopsy technique selected, and precise characterization of Gleason Score/Grade Groupings are equal determinants of accurate biopsy results. Furthermore, all specialists are required to attain appropriate learning curves to ensure optimal results. In this review, we characterize crucial aspects to consider when developing a center of excellence for prostate imaging and biopsy as well as insights regarding how to implement them.
Asunto(s)
Instituciones de Salud/normas , Biopsia Guiada por Imagen/normas , Imagen por Resonancia Magnética/métodos , Neoplasias de la Próstata/diagnóstico por imagen , Biopsia/métodos , Biopsia/normas , Humanos , Biopsia Guiada por Imagen/métodos , Curva de Aprendizaje , Masculino , Clasificación del Tumor , Grupo de Atención al Paciente/normas , Desarrollo de Programa/normas , Neoplasias de la Próstata/patología , Estados UnidosRESUMEN
The confrontation of the differential and etiological diagnosis of the infectious diseases of cancer patients, including hematopoietic stem cells transplant (HSCT) recipients, must correspond to an informed, timely decision that directly affects medical behavior that determines a better survival and quality of life for patients. The main goal of this work was to contribute to the management of these patients developing a useful tool for the clinician to make these decisions. For that, infections were grouped by compromised systems, differentiating the possible etiological agents in bacteria, viruses, fungi and parasites, highlighting the relevant diagnostic tests, mentioning the recommended techniques together with the optimal sample type for proper processing. In addition, under each group of techniques we added the item "level of requirement" to suggest what, in the opinion of the authors and the existing evidence, must be mandatory to have at local level or can be derivable to another laboratory.
Asunto(s)
Infección Hospitalaria/diagnóstico , Infección Hospitalaria/microbiología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Laboratorios de Hospital/normas , Neoplasias/complicaciones , Biopsia/normas , Técnicas de Laboratorio Clínico/métodos , Técnicas de Laboratorio Clínico/normas , Infección Hospitalaria/terapia , Exposición a Riesgos Ambientales/efectos adversos , Humanos , Inmunocompetencia , Neoplasias/terapiaRESUMEN
Resumen El enfrentamiento del diagnóstico diferencial y etiológico de las enfermedades infecciosas de los pacientes con cáncer, incluyendo los receptores de trasplante de precursores hematopoyéticos (TPH), debe corresponder a una decisión informada, oportuna y que repercuta directamente en una conducta médica que determine una mejor sobrevida y calidad de vida de los pacientes. El objetivo de este trabajo fue aportar en el manejo de estos pacientes desarrollando una herramienta útil al médico clínico para tomar estas decisiones. Para ello se agruparon las infecciones por sistemas comprometidos diferenciando los posibles agentes etiológicos en bacterias, virus, hongos y parásitos, explicitando los exámenes diagnósticos más relevantes, mencionando la o las técnicas recomendadas, junto con el tipo de muestra óptima para su adecuado procesamiento. De manera adicional, se incorporó el ítem "nivel de requerimiento" para sugerir lo que, a juicio de los autores y la evidencia existente, debe estar presente obligatoriamente en el centro o puede ser derivable a otro laboratorio.
The confrontation of the differential and etiological diagnosis of the infectious diseases of cancer patients, including hematopoietic stem cells transplant (HSCT) recipients, must correspond to an informed, timely decision that directly affects medical behavior that determines a better survival and quality of life for patients. The main goal of this work was to contribute to the management of these patients developing a useful tool for the clinician to make these decisions. For that, infections were grouped by compromised systems, differentiating the possible etiological agents in bacteria, viruses, fungi and parasites, highlighting the relevant diagnostic tests, mentioning the recommended techniques together with the optimal sample type for proper processing. In addition, under each group of techniques we added the item "level of requirement" to suggest what, in the opinion of the authors and the existing evidence, must be mandatory to have at local level or can be derivable to another laboratory.
Asunto(s)
Humanos , Laboratorios de Hospital/normas , Infección Hospitalaria/diagnóstico , Infección Hospitalaria/microbiología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Neoplasias/complicaciones , Biopsia/normas , Infección Hospitalaria/terapia , Técnicas de Laboratorio Clínico/métodos , Técnicas de Laboratorio Clínico/normas , Exposición a Riesgos Ambientales/efectos adversos , Inmunocompetencia , Neoplasias/terapiaRESUMEN
ABSTRACT Objectives: To evaluate the frequency of NIH category IV prostatitis, and the use of expressed prostatic secretions tests in an effort to improve the reliability of prostate specific antigen as an indicator, to avoid unnecessary prostate biopsy. Materials and Methods: 178 expressed prostatic secretion positive patients with serum prostate specific antigen levels of ≥ 2.5 ng / mL were included in present prospective study. The diagnostic evaluation included detailed history and physical examination, digital rectal examination, urine analysis, urine culture, and expressed prostatic secretions tests. Transrectal ultrasonography was used both to measure prostate volume and conduct 12 core prostate biopsy. Results: The prevalence of NIH category IV prostatitis was 36.9% (178 / 482) in our population of men. In our study patients (n: 178) prostate biopsy results were classified as; 66 prostatitis, 81 BPH, and 31 Pca. In asymptomatic prostatitis group, expressed prostatic secretion mean leucocyte ratio was higher compared to other two groups (p < 0.0001). The relation between number of expressed prostatic secretion leucocytes and prostatitis, benign prostate hyperplasia, and prostate cancer is analyzed. If 16 is taken as the cut of number for leucocyte presence, its sensitivity is 0.92 (AUC = 0.78 p = 0.01). Conclusions: The number of leucocytes in expressed prostatic secretion is higher in the chronic prostatitis group. If the leukocyte presence of 16 and above is taken as the cut off point, the sensitivity becomes 0.92 (AUC = 0.78). We firmly believe that our new cut off value may be used as to aid prostate specific antigen and derivates while giving biopsy decision.
Asunto(s)
Humanos , Masculino , Anciano , Próstata/patología , Hiperplasia Prostática/metabolismo , Neoplasias de la Próstata/metabolismo , Prostatitis/mortalidad , Biopsia/normas , Antígeno Prostático Específico/sangre , Próstata/metabolismo , Hiperplasia Prostática/diagnóstico , Neoplasias de la Próstata/diagnóstico , Prostatitis/clasificación , Prostatitis/patología , Biomarcadores de Tumor/metabolismo , Enfermedad Crónica , Estudios Prospectivos , Diagnóstico Diferencial , Tacto Rectal , Persona de Mediana EdadRESUMEN
OBJECTIVES: To evaluate the frequency of NIH category IV prostatitis, and the use of expressed prostatic secretions tests in an effort to improve the reliability of prostate specific antigen as an indicator, to avoid unnecessary prostate biopsy. MATERIALS AND METHODS: 178 expressed prostatic secretion positive patients with serum prostate specific antigen levels of ≥ 2.5 ng / mL were included in present prospective study. The diagnostic evaluation included detailed history and physical examination, digital rectal examination, urine analysis, urine culture, and expressed prostatic secretions tests. Transrectal ultrasonography was used both to measure prostate volume and conduct 12 core prostate biopsy. RESULTS: The prevalence of NIH category IV prostatitis was 36.9% (178 / 482) in our population of men. In our study patients (n: 178) prostate biopsy results were classified as; 66 prostatitis, 81 BPH, and 31 Pca. In asymptomatic prostatitis group, expressed prostatic secretion mean leucocyte ratio was higher compared to other two groups (p < 0.0001). The relation between number of expressed prostatic secretion leucocytes and prostatitis, benign prostate hyperplasia, and prostate cancer is analyzed. If 16 is taken as the cut of number for leucocyte presence, its sensitivity is 0.92 (AUC = 0.78 p = 0.01). CONCLUSIONS: The number of leucocytes in expressed prostatic secretion is higher in the chronic prostatitis group. If the leukocyte presence of 16 and above is taken as the cut off point, the sensitivity becomes 0.92 (AUC = 0.78). We firmly believe that our new cut off value may be used as to aid prostate specific antigen and derivates while giving biopsy decision.
Asunto(s)
Biopsia/normas , Antígeno Prostático Específico/sangre , Próstata/patología , Hiperplasia Prostática/metabolismo , Neoplasias de la Próstata/metabolismo , Prostatitis/metabolismo , Anciano , Biomarcadores de Tumor/metabolismo , Enfermedad Crónica , Diagnóstico Diferencial , Tacto Rectal , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Próstata/metabolismo , Hiperplasia Prostática/diagnóstico , Neoplasias de la Próstata/diagnóstico , Prostatitis/clasificación , Prostatitis/patologíaRESUMEN
Mucinosis (REM síndrome), es una rara enfermedad cutánea, descrita hace más de 30 años por Steigleder, afectando predominantemente a mujeres de edad avanzada. Clínicamente presenta áreas con eritema persistente, pápulas que pueden confluir, formando placas con escamas. La etiología aún no está bien esclarecida, pero diversos factores como la luz ultravioleta, trastornos inmunológicos, infecciones virales, han sido relacionados o asociados con la inducción de la misma. Se presenta un reporte de caso de un paciente masculino de 20 años, con antecedentes de haber padecido de Condilomas Acuminados, además presentó otras lesiones cutáneas caracterizadas por placas alopécicas, con discreta infiltración en número de 10 en cuero cabelludo y lesiones en placas, infiltradas, de 3 a 5 centímetros de diámetro en número de 2, de bordes precisos en tercio inferior central de la espalda. Se realizó biopsia de piel, donde se corrobora el diagnóstico de Mucinosis, posteriormente el paciente ingresó en el servicio de Nefrología en el hospital de Cárdenas con diagnóstico de Insuficiencia Renal Crónica (AU).
Mucinosis (REMsyndrome), he is a rare cutaneous, described disease he does over 30 years for Steigleder, affecting predominantly women late in years. Clinically he presents areas with persistent erythema, pápulas that they can converge, forming plates with scales. The etiology not yet is very illustrious, but various factors like the ultraviolet light, immunogenic upsets, viral infections, they have been related or associated with the induction of the same. He encounters a report of case of a masculine patient of 20 years, with background to have suffered from Condylomas Acuminados, besides he presented another cutaneous injuries characterized by plates alopécicas, with discreet infiltration in number of 10 in scalp and injuries in plates, spies, of 3 a 5 cms of diameter in number of 2, of precise borders in inferior central third part of the back. The patient accomplished biopsy of skin himself, where Mucinosis's diagnosis is corroborated, at a later time he entered in Nefrología's service at Cárdenas's hospital with diagnosis of renal chronic Insuficiencia (AU).
Asunto(s)
Humanos , Masculino , Adulto , Mucinosis/diagnóstico , Biopsia/métodos , Biopsia/normas , Condiloma Acuminado/complicaciones , Condiloma Acuminado/patología , Condiloma Acuminado/terapia , Registros Médicos , Insuficiencia Renal Crónica/complicaciones , Insuficiencia Renal Crónica/diagnóstico , Insuficiencia Renal Crónica/terapiaRESUMEN
Mucinosis (REM síndrome), es una rara enfermedad cutánea, descrita hace más de 30 años por Steigleder, afectando predominantemente a mujeres de edad avanzada. Clínicamente presenta áreas con eritema persistente, pápulas que pueden confluir, formando placas con escamas. La etiología aún no está bien esclarecida, pero diversos factores como la luz ultravioleta, trastornos inmunológicos, infecciones virales, han sido relacionados o asociados con la inducción de la misma. Se presenta un reporte de caso de un paciente masculino de 20 años, con antecedentes de haber padecido de Condilomas Acuminados, además presentó otras lesiones cutáneas caracterizadas por placas alopécicas, con discreta infiltración en número de 10 en cuero cabelludo y lesiones en placas, infiltradas, de 3 a 5 centímetros de diámetro en número de 2, de bordes precisos en tercio inferior central de la espalda. Se realizó biopsia de piel, donde se corrobora el diagnóstico de Mucinosis, posteriormente el paciente ingresó en el servicio de Nefrología en el hospital de Cárdenas con diagnóstico de Insuficiencia Renal Crónica (AU).
Mucinosis (REMsyndrome), he is a rare cutaneous, described disease he does over 30 years for Steigleder, affecting predominantly women late in years. Clinically he presents areas with persistent erythema, pápulas that they can converge, forming plates with scales. The etiology not yet is very illustrious, but various factors like the ultraviolet light, immunogenic upsets, viral infections, they have been related or associated with the induction of the same. He encounters a report of case of a masculine patient of 20 years, with background to have suffered from Condylomas Acuminados, besides he presented another cutaneous injuries characterized by plates alopécicas, with discreet infiltration in number of 10 in scalp and injuries in plates, spies, of 3 a 5 cms of diameter in number of 2, of precise borders in inferior central third part of the back. The patient accomplished biopsy of skin himself, where Mucinosis's diagnosis is corroborated, at a later time he entered in Nefrología's service at Cárdenas's hospital with diagnosis of renal chronic Insuficiencia (AU).
Asunto(s)
Humanos , Masculino , Adulto , Biopsia/métodos , Mucinosis/diagnóstico , Biopsia/normas , Condiloma Acuminado/complicaciones , Condiloma Acuminado/patología , Condiloma Acuminado/terapia , Registros Médicos , Insuficiencia Renal Crónica/complicaciones , Insuficiencia Renal Crónica/diagnóstico , Insuficiencia Renal Crónica/terapiaRESUMEN
Entomophtoramycosis is a type of subcutaneous mycosis which includes both basidiobolomycosis and conidiobolomycosis; the latter is caused by Conidiobolus coronatus, a saprophytic fungus which lives in tropical soils. This mycosis characteristically affects the paranasal sinuses and oropharynx, with the potential to deform the face in patients without apparent immunodeficiency. It has a chronic course of infection with a tendency to form granulomas visible using histology. We present the case of a 28 year-old male agricultural worker, with a clinical profile of 6 months' evolution of rhinofacial tumefaction, nasal obstruction and post-nasal drip who was diagnosed with conidiobolomycosis by means of tissue culture after multiple biopsies of the facial area. The patient received antifungal treatment with amphotericin B and subsequently with itraconazol, resulting in a dramatic improvement without the need for surgical treatment; itraconazol was administered for one year and there was no evidence of relapse at the end of this period. Due to the low frequency of this disease there is no established treatment strategy; however, the use of azoles such as itraconazol with or without adjuvant surgical treatment is increasingly seen in case reports. The present report adds to the clinical experience in Colombia of this rare mycosis and also describes the long-term clinical and therapeutic response.
Asunto(s)
Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Conidiobolus/efectos de los fármacos , Dermatomicosis/fisiopatología , Cara/fisiopatología , Granuloma/fisiopatología , Itraconazol/uso terapéutico , Biopsia/normas , HumanosRESUMEN
At present times, general surgeons are continuously faced to evaluate patients with pigmented lesions. Thus, is very important that surgeons acquire adequate knowledge not only to distinguish between suspicious lesion and non suspicious lesion, but also to correctly assess when and how to perform a skin biopsy. The early detection of melanoma and non melanoma skin cancer is one of the most important factors to achieve a better prognosis. The main objective of this article is to provide surgeons some tips and pitfalls to help accurate the evaluation and diagnosis of pigmented lesions. The authors also want to stress out the importance of the team work between surgeons and dermatologist, due that is well documented that multidisciplinary approach to skin cancer raises the possibilities of early diagnosis, adequate treatment and better results for patients with skin cancer.
En la actualidad, el cirujano continuamente se ve enfrentado a evaluar distintos tipos de lesiones cutáneas en los pacientes, por lo que debe tener conocimientos de las características que hacen que una lesión sea sospechosa o no, para evaluar correctamente cuándo y cómo realizar una biopsia de una lesión cutánea. El diagnóstico precoz, tanto del melanoma como del cáncer de piel no melanoma, ha demostrado ser clave para mejorar el pronóstico de nuestros pacientes. Este artículo pretende entregar algunas claves para afinar la evaluación y diagnóstico de las lesiones pigmentadas. Es muy importante también, recalcar la importancia del trabajo conjunto de los cirujanos con los dermatólogos, ya que la evaluación y manejo multidisciplinario mejora sustancialmente el diagnóstico, tratamiento y resultados de los pacientes con cáncer de piel.
Asunto(s)
Humanos , Biopsia/normas , Neoplasias Cutáneas/patología , Selección de Paciente , Biopsia/efectos adversos , Enfermedades de la Piel/patología , Factores de RiesgoRESUMEN
Introduction: Inflammatory bowel disease comprises two major categories: Crohn's disease and ulcerative rectocolitis, both with different clinical and histological aspects, causing sometimes significant morbidity. Objectives: Choose and apply standardized and quantified histopathological diagnosis method, and compare the results and quality index with the original diagnosis. Materials and methods: 43 histological colonoscopic biopsies of 37 patients were re-evaluated by standardized system. Results and discussion: The original diagnoses were more inconclusive (23.3%) than those standardized (2.3%). The agreement with gold standard (clinical, colonoscopical, and radiological diagnosis) was higher on standardized diagnoses (95.3%) than in original (74.4%), especially in relation to Crohn's disease, which percentages were 92.3% and 46.1%, respectively. The quality index was calculated in conclusive diagnosis of each method. For ulcerative rectocolitis, both methods showed sensitivity and negative predictive value of 100%; otherwise the original diagnosis demonstrated specificity of 85.7%, positive predictive value of 96.3% and accuracy of 97.0%, and the standardized diagnosis 92.3%, 96.7% and 97.6%, respectively. For Crohn's disease, there is specificity and positive predictive value of 100% in both methods; the original diagnosis showed sensitivity of 85.7%, negative predictive value of 96.3% and accuracy of 97%, while for the standardized diagnoses 92.3%, 96.7%, and 97.6%, respectively. Conclusion: The standardized diagnosis presented a higher percentage of correct and conclusive diagnoses than those presented in the original diagnosis, especially for Crohn's disease, as well as equal or slightly higher values in some quality index...
Introdução: Duas são as formas de manifestação da doença intestinal inflamatória: doença de Crohn e retocolite ulcerativa, ambas com evolução clínica, tratamento e aspectos histopatológicos diferentes, causando, por vezes, significativa morbidade. Objetivos: Escolher e aplicar método padronizado e quantificado de diagnóstico histopatológico e comparar os resultados e os índices de qualidade, com os dos diagnósticos originais. Materiais e métodos: Foram reavaliadas histologicamente 43 biópsias colonoscópicas seriadas de 37 pacientes por sistema padronizado. Resultado e discussão: Os diagnósticos originais foram mais inconclusivos (23,3%) do que os padronizados (2,3%). A concordância com o padrão-ouro (diagnóstico clínico, colonoscópico e radiológico) foi maior nos diagnósticos padronizados (95,3%) do que nos originais (74,4%), principalmente em relação à doença de Crohn, cujos percentuais foram de 92,3% e 46,1%, respectivamente. Para retocolite ulcerativa, ambos os métodos apresentaram sensibilidade e valor preditivo negativo de 100%; já nos diagnósticos originais, foram verificados especificidade de 85,7%, valor preditivo positivo de 96,3% e acurácia de 97%, e nos diagnósticos padronizados, 92,3%, 96,7% e 97,6%, respectivamente. Para doença de Crohn, verificaram-se especificidade e valor preditivo positivo de 100% nos dois métodos; nos diagnósticos originais, sensibilidade de 85,7%, valor preditivo negativo de 96,3% e acurácia de 97%, e nos diagnósticos padronizados, 92,3%, 96,7% e 97,6%, respectivamente. Conclusão: O diagnóstico padronizado apresentou maior percentual de diagnósticos corretos e conclusivos do que os apresentados no diagnóstico original, principalmente para doença...
Asunto(s)
Humanos , Biopsia/normas , Enfermedad de Crohn/diagnóstico , Proctocolitis/diagnóstico , Técnicas y Procedimientos Diagnósticos/normas , Enfermedad de Crohn/patología , Enfermedades Inflamatorias del Intestino/diagnóstico , Valor Predictivo de las Pruebas , Proctocolitis/patologíaRESUMEN
BACKGROUND: Although the prevalence of celiac disease in the USA approaches 1%, most cases are undiagnosed, in part, because of low adherence to the recommendation of submitting at least four specimens during duodenal biopsy. We aimed to determine whether physician and practice characteristics are associated with adherence to this recommendation. MATERIALS AND METHODS: We used a large national pathology database to identify all adult patients who underwent duodenal biopsy during 2006-2009. Hierarchical modeling was used to determine whether procedure volume, the number of gastroenterologists per endoscopy suite, and the number of gastroenterologists per capita of the zip code of the practice were associated with adherence. RESULTS: We identified 92 580 patients (67% female, mean age 53.5 years) who met our inclusion/exclusion criteria. Specimens were submitted by 669 gastroenterologists from 200 endoscopy suites, located in 191 zip codes, with a mean of 3.4 gastroenterologists per suite. On multivariate analysis, a higher procedure volume was associated with a decreased adherence [odds ratio (OR) for each additional 100 procedures, 0.92; 95% confidence interval (CI), 0.88-0.97; P=0.002]. An increased adherence was reported for gastroenterologists working at suites with higher numbers of gastroenterologists (OR for each additional gastroenterologist, 1.08; 95% CI, 1.04-1.13; P<0.001) but not for a higher gastroenterologist density in the zip code of the practice (OR for each additional gastroenterologist per capita, 1.01; 95% CI, 0.99-1.03; P=0.21). CONCLUSION: High-volume physicians exhibit lower rates of adherence to biopsy guidelines, possibly because of the additional time required to submit at least four specimens. In contrast, a greater number of endoscopists working in an endoscopy suite are associated with an increased adherence, possibly because of peer education.
Asunto(s)
Enfermedad Celíaca/patología , Adhesión a Directriz/estadística & datos numéricos , Guías de Práctica Clínica como Asunto , Calidad de la Atención de Salud , Adulto , Anciano , Biopsia/normas , Biopsia/estadística & datos numéricos , Bases de Datos Factuales , Duodeno/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , New York , Puerto Rico , Carga de Trabajo/estadística & datos numéricosAsunto(s)
Enfermedad Celíaca/dietoterapia , Enfermedad Celíaca/diagnóstico , Técnicas de Diagnóstico del Sistema Digestivo/normas , Dieta Sin Gluten/normas , Gastroenterología/normas , Salud Global/normas , Sociedades Médicas/normas , Biopsia/normas , Enfermedad Celíaca/epidemiología , Endoscopía Gastrointestinal/normas , Pruebas Genéticas/normas , Humanos , Cooperación del Paciente , Valor Predictivo de las Pruebas , Pruebas Serológicas/normas , Resultado del TratamientoRESUMEN
OBJECTIVE: To determine the efficacy of a quality control strategy in cervical cytology in the detection of high-grade squamous intraepithelial lesions. METHODS: Forty-two patients were selected who underwent a Pap smear and cervical uterine biopsy between April 2008 and December 2009, with evidence of a high-grade squamous intraepithelial lesion in one or both tests. The statistical parameters of the smear test were calculated before and after systematic meetings for review of the archived test results (6 years), in which the following was done: interobserver diagnostic consensus; cytohistological correlation, with the latter as gold standard; and evaluation of the therapeutic status of each patient. RESULTS: Once these controls were applied, it was noted that sensitivity and positive likelihood ratio of the test for high-grade squamous intraepithelial lesion increased 9.5% (34.5 to 44%) and 0.45% (1.64 to 2.09%), respectively, while specificity remained at 79%. Reduction in interference of false-negative results associated with errors in the analytical phase of the cytological productive process gave an estimate of failures in collection of the specimens (pre-analytical phase). CONCLUSION: In addition to improving the performance of the cytological diagnosis of the high-grade squamous intraepithelial lesion, the proposed quality control strategy allows a reflection on the causes of incorrect or conflicting scrutiny.
Asunto(s)
Biopsia , Carcinoma de Células Escamosas/patología , Cuello del Útero/patología , Prueba de Papanicolaou , Garantía de la Calidad de Atención de Salud , Displasia del Cuello del Útero/patología , Neoplasias del Cuello Uterino/patología , Frotis Vaginal , Algoritmos , Biopsia/normas , Biopsia/estadística & datos numéricos , Carcinoma de Células Escamosas/diagnóstico , Estudios Transversales , Reacciones Falso Negativas , Reacciones Falso Positivas , Femenino , Humanos , Invasividad Neoplásica , Valor Predictivo de las Pruebas , Control de Calidad , Sensibilidad y Especificidad , Neoplasias del Cuello Uterino/diagnóstico , Frotis Vaginal/normas , Frotis Vaginal/estadística & datos numéricos , Displasia del Cuello del Útero/diagnósticoRESUMEN
Objective: To determine the efficacy of a quality control strategy in cervical cytology in the detection of high-grade squamous intraepithelial lesions. Methods: Forty-two patients were selected who underwent a Pap smear and cervical uterine biopsy between April 2008 and December 2009, with evidence of a high-grade squamous intraepithelial lesion in one or both tests. The statistical parameters of the smear test were calculated before and after systematic meetings for review of the archived test results (6 years), in which the following was done: interobserver diagnostic consensus; cytohistological correlation, with the latter as gold standard; and evaluation of the therapeutic status of each patient. Results: Once these controls were applied, it was noted that sensitivity and positive likelihood ratio of the test for high-grade squamous intraepithelial lesion increased 9.5% (34.5 to 44%) and 0.45% (1.64 to 2.09%), respectively, while specificity remained at 79%. Reduction in interference of false-negative results associated with errors in the analytical phase of the cytological productive process gave an estimate of failures in collection of the specimens (pre-analytical phase). Conclusion: In addition to improving the performance of the cytological diagnosis of the high-grade squamous intraepithelial lesion, the proposed quality control strategy allows a reflection on the causes of incorrect or conflicting scrutiny.
Objetivo: Determinar a eficácia de uma estratégia de controle de qualidade em colpocitologia na detecção da lesão intraepitelial escamosa de alto grau. Métodos: Foram selecionadas 42 pacientes que realizaram Papanicolaou e biópsia cervicouterina entre abril de 2008 e dezembro de 2009, com evidência de lesão intraepitelial escamosa de alto grau em um ou em ambos os exames. Os parâmetros estatísticos do esfregaço foram calculados antes e após reuniões sistematizadas de revisão dos exames arquivados (6 anos), nas quais se procedeu a: consensualização diagnóstica interobservadores; correlação cito-histológica, sendo a última padrão-ouro; e avaliação do status terapêutico de cada paciente. Resultados: Aplicados tais controles, observou-se que a sensibilidade e a likelihood ratio positiva do teste para lesão intraepitelial escamosa de alto grau aumentaram 9,5% (34,5 para 44%) e 0,45% (1,64 para 2,09%), respectivamente, enquanto sua especificidade se manteve em 79%. A redução da interferência dos falso-negativos associados a erros na fase analítica do processo produtivo citológico traz estimativa das falhas de coleta do material (fase pré-analítica). Conclusão: Além de melhorar o desempenho do diagnóstico colpocitológico de lesão intraepitelial escamosa de alto grau, a estratégia de controle de qualidade proposta permite refletir sobre as causas de escrutínio incorreto ou discordante.
Asunto(s)
Humanos , Femenino , Biopsia , Carcinoma de Células Escamosas/patología , Displasia del Cuello del Útero/patología , Cuello del Útero/patología , Garantía de la Calidad de Atención de Salud , Neoplasias del Cuello Uterino/patología , Frotis Vaginal , Algoritmos , Biopsia/normas , Biopsia/estadística & datos numéricos , Carcinoma de Células Escamosas/diagnóstico , Displasia del Cuello del Útero/diagnóstico , Estudios Transversales , Reacciones Falso Negativas , Reacciones Falso Positivas , Invasividad Neoplásica , Valor Predictivo de las Pruebas , Control de Calidad , Sensibilidad y Especificidad , Neoplasias del Cuello Uterino/diagnóstico , Frotis Vaginal/normas , Frotis Vaginal/estadística & datos numéricosRESUMEN
BACKGROUND: Brain tumors are one of the leading cancers worldwide; in the National Institute of Neurology and Neurosurgery (INNN) these tumors are the leading cause of morbitity and mortality. OBJECTIVE: Standardize biopsies, colletion, processing and storage biologic material of molecular studies. METHODS: with a previously signed surgical consent, a tumor and blood biopsy was done to 134 patients. Their DNA was extracted and a database was filled considering technical, ethical and legal aspects. In order to have optimal biologic material the procedure was standardized between the surgical and research laboratory teams. RESULTS: The biopsy, transportation, processing and storage were standardized. 134 patients were included (67 male and 67 female) with an average age of 46.28 years (range 15-81). The most frequently biopsied tumor was the meningioma (42%). The integrity of the obtained material was determined by agarose gel electrophoretic analysis. CONCLUSION: the INNN biobank has a standardized system that biopsies, processes and stores optimum quality biologic material that will be the basis of future molecular studies.
Asunto(s)
Bancos de Muestras Biológicas/normas , Neoplasias del Sistema Nervioso Central/patología , ADN de Neoplasias , Meningioma/patología , Neoplasias Neuroepiteliales/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Bancos de Muestras Biológicas/organización & administración , Biopsia/normas , Sistema Nervioso Central/química , Sistema Nervioso Central/patología , Neoplasias del Sistema Nervioso Central/química , Neoplasias del Sistema Nervioso Central/genética , Neoplasias del Sistema Nervioso Central/secundario , Neoplasias de los Nervios Craneales/química , Neoplasias de los Nervios Craneales/genética , Neoplasias de los Nervios Craneales/patología , ADN de Neoplasias/análisis , ADN de Neoplasias/genética , ADN de Neoplasias/aislamiento & purificación , Bases de Datos Factuales , Electroforesis en Gel de Agar , Femenino , Humanos , Masculino , Meningioma/química , Meningioma/genética , México , Persona de Mediana Edad , Neoplasias Neuroepiteliales/química , Neoplasias Neuroepiteliales/genética , Neoplasias del Sistema Nervioso Periférico/química , Neoplasias del Sistema Nervioso Periférico/genética , Neoplasias del Sistema Nervioso Periférico/patología , Preservación Biológica/métodos , Preservación Biológica/normas , Garantía de la Calidad de Atención de Salud , Manejo de Especímenes/normas , Nervios Espinales/química , Nervios Espinales/patología , Transportes/normas , Adulto JovenRESUMEN
BACKGROUND/AIM: The main objective of this study was to describe the profile of patients who were benefitted in a collective effort to perform liver biopsies in Bahia, Brazil. METHOD: A cross-sectional study was conducted with a sample composed of all the patients who were submitted to liver biopsy during a collective effort carried out in Bahia between July 2007 and November 2009. At the time of the procedure, date on the age and gender of patients and the reason for performing the biopsy were recorded. Data on the degree of fibrosis and the presence of co-morbidities. Following statistical analysis, the frequency of the liver diseases that led to the biopsy procedure was described, and the profile of the patients was stratified into groups according to the most prevalent etiologies. RESULTS: Of the 550 patients evaluated, 55.3% were men and 44.7% women. Mean age was 46.63 ± 11.59 years and there was no statistically significant difference in age between males and females. Of the 550 patients, 72% had hepatitis C and the mean age of these patients was 48.49 ± 10.1 years, significantly higher than the mean age of the patients with hepatitis B (40.41 ± 12.43 years). Furthermore, 70.7% of the patients with hepatitis C were between 41 and 60 years of age. The most frequent fibrosis grade was F2 (44%) and the prevalence of advanced fibrosis was 27.7%. Overall, 85 patients, most of them men, had some degree of iron overload. With respect to the safety of the biopsy procedure, severe complications occurred in only two patients. CONCLUSION: Hepatitis C is the predominant liver disease that demanded liver biopsy. The profile of the patients who benefitted from this collective effort is similar to that of patients in the rest of the country. Moreover, non-Ultrasonography guided liver biopsy is safe and the collective effort to carry out liver biopsies in Bahia was found to be a viable venture.
Asunto(s)
Biopsia/normas , Hepatopatías/epidemiología , Hígado/patología , Adulto , Biopsia/efectos adversos , Brasil/epidemiología , Distribución de Chi-Cuadrado , Comorbilidad , Estudios Transversales , Femenino , Hepatitis B/epidemiología , Hepatitis B/patología , Hepatitis C/epidemiología , Hepatitis C/patología , Hepatitis Autoinmune/epidemiología , Hepatitis Autoinmune/patología , Humanos , Hipertensión Portal/epidemiología , Hipertensión Portal/patología , Cirrosis Hepática/epidemiología , Cirrosis Hepática/patología , Hepatopatías/diagnóstico , Hepatopatías/patología , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Derivación y Consulta/normas , Medición de Riesgo , Factores de Riesgo , Índice de Severidad de la Enfermedad , Factores de TiempoRESUMEN
INTRODUCTION: After the clinical diagnosis of leprosy, classification methods are necessary to define a treatment and prognosis of patients consistent with bacterial load. Bacteria are detected in skin smear, and bacterial load typically is established by the internationally used Ridley's logarithmic scale, However, in Colombia an alternative semiquantitative scale is used. OBJECTIVE: The interobserver reproducibility was established for the Ridley and Colombia scales, and the level of correlation-matching was identified between the bacillary indices obtained in order to assess the degree of interchangeability. MATERIALS AND METHODS: Standardization was attained by a reading of the smears by 2 readers with subsequent, blinded evaluation of inter-observer agreement. Each reader quantified the bacterial load of for each sample (n=325) using the Colombian and the Ridley scales. The degree of interobserver agreement was assessed with weighted kappa coefficient. The level of correlation and agreement between the measurements of the bacillary index was established with coefficient of Lin. RESULTS: The interobserver weighted kappa coefficient was 0.83 for the Colombia scale and 0.85 for the Ridley scale. The Lin coefficient was 0.96 for the correlation-matching of bacillary indexes. CONCLUSIONS: Interobserver agreement obtained for both scales was excellent as the correlation-matching bacillary indices determined with both methods. With the cut-off points yielded a good level of agreement, ensuring interchangeability between the scales defining the high or low bacterial load.